1 Department of Pharmacology, Institute of Pharmacology and Toxicology, School of Medicine, Universidad Complutense, 28040 Madrid; and 2 Department of Pharmacology, School of Medicine, Universidad Autónoma, 28029 Madrid, Spain
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The maturation in the vasodilator response
to nitric oxide (NO) in isolated intrapulmonary arteries was analyzed
in newborns and 15- to 20-day-old piglets. The vasodilator responses to
NO gas but not to the NO donor sodium nitroprusside increased with age.
The inhibitory effects of the superoxide dismutase inhibitor diethyldithiocarbamate and xanthine oxidase plus hypoxanthine and the
potentiation induced by superoxide dismutase and MnCl2 of
NO-induced vasodilatation were similar in the two age groups. Diphenyleneiodonium (NADPH oxidase inhibitor) potentiated the response
to NO, and this effect was more pronounced in the older animals. The
nonselective cyclooxygenase inhibitors indomethacin and meclofenamate
and the preferential cyclooxygenase-1 inhibitor aspirin augmented
NO-induced relaxation specifically in newborns, whereas the selective
cycloxygenase-2 inhibitor NS-398 had no effect. The expressions of
-actin, cycloxygenase-1, and cycloxygenase-2 proteins were similar,
whereas Cu,Zn-superoxide dismutase decreased with age. Therefore, the
present data suggest that the maturational increase in the
vasodilatation of NO in the pulmonary arteries during the first days of
extrauterine life involves a cycloxygenase-dependent inhibition of
neonatal NO activity.
piglet; superoxide; newborn
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
AT BIRTH AND ALONG THE FIRST days and weeks of extrauterine life, several important functional and structural changes occur in the pulmonary circulation to replace the placenta for gas exchange (12). During the first minutes of extrauterine life, as the lung becomes responsible for blood oxygenation, there is an 8- to 10-fold increase in pulmonary blood flow, and pulmonary arterial pressure falls from suprasystemic levels in the fetus to about half of systemic values (10). This acute decline in pulmonary vascular resistance is triggered by lung ventilation, oxygenation, and increased shear stress (12). The endothelium-derived vasodilators nitric oxide (NO) and cyclooxygenase (Cox)-derived metabolites, mainly prostacyclin (PGI2), are critically involved in these changes (30). In fact, inhibition of Cox or NO synthases attenuates the birth-related decline in pulmonary vascular resistances in lambs (1, 9, 29).
A second postnatal maturational phase of pulmonary vascular resistance reduction takes place over the first 2-3 wk of extrauterine life in pigs and humans to reach the pulmonary pressure values characteristic of the adult life (14). During this period, the pulmonary circulation is highly vulnerable to develop pulmonary hypertension in response to exogenous insults. Several groups have consistently reported an increase in endothelium-dependent vasodilation to ACh or exogenous NO during the first days of extrauterine life in rabbit (21), lamb (2, 15, 32), and piglet (4, 18, 32, 37) pulmonary arteries, which seems to be a primary factor for the postnatal adaptative maturation. This maturational process is specific to the pulmonary circulation (20, 25, 33, 34), but the mechanisms involved in the age-dependent changes are unclear. Although the responses to exogenous NO gas increase with age (34, 37), the vasodilator responses to the NO donor sodium nitroprusside (18) or the cGMP analog 8-bromo-cGMP (34) remain unchanged. These results indicate that changes in the activity of soluble guanylate cyclase and cGMP-dependent phosphodiesterase are not essential to explain the maturation of NO-dependent relaxation. In fact, the activity and expression of soluble guanylate cyclase decrease postnatally in rat lung (3). Because NO and nitroprusside exhibit a different susceptibility to be inactivated by superoxide (19), an attractive hypothesis to explain the age-dependent difference in NO-induced relaxation involves an elevated metabolism of NO resulting from excess tissue levels of superoxide. Therefore, the aim of the present study was to further analyze the maturational changes in the response to exogenous NO and to determine the possible role of superoxide-generating and -metabolizing enzymatic pathways.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
All of the procedures conform with the Guide for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1996).
Tissue preparation.
Male piglets of 3-18 h (n = 25) or 15-20 days
of age (n = 29) were used in this study. The lungs were
rapidly immersed in cold (4°C) Krebs solution (composition in mM: 118 NaCl, 4.75 KCl, 25 NaHCO3, 1.2 MgSO4, 2.0 CaCl2, 1.2 KH2PO4, and 11 glucose). The pulmonary arteries (third branch with an internal diameter of
~0.5-1.5 mm) were carefully dissected free of surrounding tissue and cut into rings of 2-3 mm length (26-28).
Except where otherwise stated, the endothelium was removed by gently
rubbing the intimal surface of the rings with a metal rod. The
endothelium removal procedure was verified by the inability of ACh
(106 M) to relax arteries precontracted with
norepinephrine (10
6 M). Rings were mounted between two
hooks under 0.5 g of tension in a 5-ml organ bath filled with
Krebs solution at 37°C gassed with a 95% O2-5%
CO2 gas mixture as previously described
(26-28). The contraction was measured by an isometric
force transducer (model PRE 206-4 from Cibertec, Madrid, Spain; or
Grass model FT03) using data acquisition software and hardware (REGXPC
computer program from Cibertec or Powerlab hardware and Chart version
3.4 software from AD Instruments, Castle Hill, Australia).
Western blot analysis.
Pulmonary arteries were frozen in liquid nitrogen and stored at
70°C. Frozen arteries were homogenized in a glass potter in a
buffer of the following composition: 1 mM sodium vanadate, 1% SDS, and
10 mM Tris. The homogenate was centrifuged at 10,000 revolutions/min
for 1 min. The protein content in the supernatant was determined using
the Bradford assay (reagents from Bio-Rad). Western blotting was
performed with 20 µg protein from the supernatant/lane. SDS-PAGE
(12% acrylamide) was performed using the method of Laemmli (16) in a minigel system (Bio-Rad). The proteins were
transferred to polyvinylidene difluoride membranes overnight and
incubated with rabbit anti-Cu,Zn-SOD polyclonal (1:1,400; StressGen
Biotechnologies), goat anti-Cox-1 monoclonal (1:1,000 dilution;
SantaCruz Biotechnology), rabbit anti-Cox-2 polyclonal (1:1,000; Cayman
Chemical), or mouse anti-
-smooth muscle-actin monoclonal (1:400;
Sigma) antibodies and then with the respective secondary horseradish
peroxidase-conjugated antibodies. The bands were visualized by enhanced
chemiluminiscence (Amersham) and quantified using image analysis
software (NIH Image). The bands of actin in pulmonary arteries were
similar in the two experimental groups (15- to 20-day-old animals were
103 ± 10% of those of newborns, P > 0.05) and
were used as a reference for the expression of other proteins. Thus the
results of SOD, Cox-1, and Cox-2 protein expression were normalized
with respect to the bands of actin and expressed as a percentage of the
data of 3- to 18-h-old animals.
Drugs.
U-46619 was from Alexis Biochemicals (Läufelfingen, Switzerland),
ODQ was from Tocris Cookson (Bristol, UK), SKF-525A was from RBI,
AA-861 was from Takeda, meclofenamate was from Warner Lambert, and all
other drugs were from Sigma Chemical (Alcobendas, Spain). Drugs were
dissolved initially in distilled deionized water (except for
thapsigargin, AA-861, and ODQ, which were dissolved in dimethyl
sulfoxide, indomethacin and meclofenamate in ethanol, and HX in 0.1%
NaOH) to prepare a 102 or 10
3 M stock
solution, and further dilutions were made in Krebs solution.
Statistical analysis. Results are expressed as means ± SE, and n reflects the number of animals from which the arterial rings were obtained. Individual cumulative concentration-response curves were fitted to a logistic equation. The drug concentration exhibiting 30% relaxation was calculated from the fitted concentration-response curves for each ring and expressed as negative log molar (-log [IC30]). The magnitude of the effect of agents modulating the response to NO agonists was quantified by the log dose ratios, which represents the distance between the two curves, i.e., log (dose ratio) = log [IC30 (control)/IC30 (drug)]. Statistically significant differences between groups were calculated by an ANOVA followed by a Newman Keuls test. P < 0.05 was considered statistically significant.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Developmental changes in NO- and NO donor-induced vasodilatation.
The vasodilator response to exogenously added NO increased
significantly with postnatal development, and this effect was similarly observed in arteries preconstricted with KCl, U-46619, and endothelin-1 (Fig. 1). However, in contrast to
exogenous NO gas, the NO donor nitroprusside produced a relaxant
response in arteries stimulated with KCl, U-46619, or endothelin-1 that
was similar in the two age groups (Fig.
2).
|
|
|
Role of SOD and increased and decreased superoxide anion.
The inhibition of endogenous SOD by DETCA (103 M)
produced a strong inhibitory effect on NO-induced relaxation, whereas
addition of exogenous SOD increased it (Fig.
4). A trend for an increased effect of
exogenous SOD in 15- to 20-day old animals (log dose ratio = 0.91 ± 0.15) compared with that in 3- to 18-h animals (0.49 ± 0.15) was observed, but these differences did not reach statistical
significance. The effects of DETCA were similar at the two ages (log
dose ratios =
0.65 ± 0.07 and
0.55 ± 0.2 in arteries from 3- to 18-h- and 15- to 20-day-old animals, respectively, P > 0.05). Therefore, in the presence of DETCA or SOD,
the age-dependent increase in NO-induced relaxation was maintained
(Fig. 4C). Furthermore, a weak but significant reduction in
SOD protein expression was observed at 15-20 days compared with
3-18 h (Fig. 4, D and E). The effects of
MnCl2, which is a membrane-permeable SOD-like compound, on
NO-induced relaxation were very similar to those observed
for SOD (Fig. 5). A nonsignificant trend
for an increased effect of MnCl2 in 15- to 20-day-old
animals (log dose ratio = 0.76 ± 0.13) compared with 3- to
18-h animals (0.40 ± 0.22, P > 0.05) was also observed. Figure 5 also shows that the exogenous superoxide
anion-generating system XO plus HX also produced a similar inhibitory
effect on NO-induced relaxation at the two developmental stages.
|
|
Role of endogenous superoxide-generating systems.
The source of superoxide that could be responsible for the destruction
of NO was analyzed using pharmacological tools to inhibit different
potential enzymatic superoxide-generating systems (7). We
used DPI [inhibitor of membrane NAD(P)H oxidase], L-NAME
(inhibitor of NO synthase), oxypurinol (inhibitor of XO), and rotenone
(inhibitor of complex I of the mitochondrial electron transport chain).
DPI significantly potentiated the relaxant effect of NO at the two ages, whereas the other inhibitors had no effect on these responses (Fig. 6). However, DPI-induced
potentiation was significantly higher in the 15- to 20-day-old animals
(log dose ratio = 0.58 ± 0.07) compared with the 3- to 18-h
animals (0.24 ± 0.03, P < 0.05).
|
|
|
Isoforms of Cox involved.
To further determine the role of Cox isoforms (Cox-1 and Cox-2)
involved in the reduced effect of NO, we studied the effects of
meclofenamate, another nonselective Cox inhibitor chemically unrelated
to indomethacin, aspirin, which at 5 × 105 M is a
fairly selective Cox-1 inhibitor, and NS-398, a selective Cox-2
inhibitor. None of these drugs produced any effect on NO-induced effects in the older animals (Fig.
9B). Meclofenamate and
aspirin, however, significantly potentiated NO responses in neonates
(log dose ratio 0.34 ± 0.06 and 0.35 ± 0.14, respectively,
Fig. 9A) to a similar extent to that observed with
indomethacin so that both drugs abolished the maturational differences
(Fig. 9C). In contrast, NS-398 had no significant effect.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the present paper, we found that, in isolated pulmonary arteries, the relaxant responses to exogenous NO increased during the first days of extrauterine life, whereas the responses to the NO donor sodium nitroprusside remained unchanged. All of these results are consistent with data previously published in piglet, rabbit, and lamb pulmonary arteries (2, 4, 15, 18, 21, 32, 34, 37). The most interesting finding of this study is that the inhibitors of Cox-1 specifically potentiated the responses to NO in the newborn animals so that, in their presence, the age-dependent changes were no longer observed. Other attempts to modulate the response to exogenous NO produced similar effects in newborns than in older animals. In addition, the maturation of the response to NO was not related to changes in the patterns of expression of SOD, Cox-1, and Cox-2 proteins.
NO- and nitroprusside-induced vasodilatation in piglet pulmonary arteries has been related to a cGMP-dependent activation of the sarcoplasmic reticulum Ca2+-ATPase (8). The vasodilator effects of NO in the two age groups were similarly inhibited by ODQ and thapsigargin (inhibitors of guanylate cyclase and the sarcoplasmic reticulum Ca2+-ATPase, respectively). Therefore, these results indicate that no differences in the NO/cGMP pathway beyond the activation of guanylate cyclase are responsible for the maturation of the NO response. Early maturational changes in phosphodiesterase 5 (PDE5) expression in mouse and sheep lung tissue have been proposed to account for the postnatal decrease in pulmonary vascular resistance (13). However, unchanged age-dependent responses to nitroprusside as described herein and by other authors (18) are not consistent with NO-dependent increases being the result of changes in PDE5 activity.
In contrast to NO, the responses to nitroprusside are unaffected by basal or exogenously stimulated superoxide production (19). Therefore, we hypothesized that age-dependent differences in NO- but not in nitroprusside-induced relaxation could be related to changes in the reactive oxidant species. Likewise, Morecroft and McLean (21) reported that the ACh-induced vasodilatation was preferentially increased by SOD in neonatal rabbits compared with older animals and suggested that the age-dependent differences could be the result of reduced SOD activity at birth. However, in piglets, the potentiation of the effects of exogenous SOD was, if any, higher in older animals (present results and Ref. 34). In the present study, the membrane-permeable SOD mimetic MnCl2 also potentiated the vasodilator effects of NO, but these effects were similar to those of SOD. It is likely that the concentration of MnCl2 used was not maximally effective, but the use of higher concentrations was limited by its solubility in Krebs solution. Conversely, Cu,Zn-SOD inhibition by DETCA produced similar inhibitory effects in both groups. Moreover, the inhibitory effects of the superoxide-generating system XO plus HX were also similar in the two groups. In addition, the expression of Cu,Zn-SOD protein was lower in older animals. Thus there is a maturation in the expression of Cu,Zn-SOD protein in piglet pulmonary arteries. However, these age-dependent changes in SOD expression and the effects of SOD mimetics and inhibitors cannot explain those of the responses to NO. Nevertheless, in the present study, we did not address a possible role of other isoforms of SOD (e.g., the mitochondrial Mn-SOD isoenzyme) or nonenzymatic scavengers of superoxide. Therefore, these results clearly indicate that a reduced Cu,Zn-SOD activity does not account for the reduced NO activity at birth but do not fully exclude an increased tissue superoxide in newborn animals.
In the search for a maturational change in the source of superoxide, we
investigated the effects of inhibitors of several potential enzymatic
sources of superoxide. In pulmonary arteries, XO, NO synthases,
complex I of the respiratory electron transport chain,
5-lypoxygenase, and cytochrome P-450 are not important sources of superoxide, as indicated by the lack of inhibitory effect of
oxypurinol, L-NAME, rotenone, AA-861, and SKF-525A, respectively. In contrast, DPI potentiated NO-induced relaxation. DPI
is a membrane NADPH oxidase inhibitor but also inhibits complex I of the mitochodrial electron transport chain. Because rotenone (which does not affect NADPH oxidase) failed to modify NO-induced relaxation, the effects of DPI should be attributed to its inhibitory effect on NADPH oxidase. This is consistent with previous findings that
indicate that NADPH oxidase is a major source of oxidative stress in
pulmonary and systemic vessels under physiological and pathological
conditions (11, 19, 36). However, the potentiation induced
by DPI was greater in the older animals. Therefore, none of the
above-mentioned enzymatic systems is involved in the maturation of the
responses to NO. In contrast, the nonselective Cox inhibitor indomethacin specifically potentiated the responses to NO in newborns so that in its presence NO-induced relaxation was similar in neonates and in older animals. We then tested the effects of meclofenamate, another nonselective Cox inhibitor structurally unrelated to
indomethacin; NS-398, a selective Cox-2 inhibitor; and aspirin, which
at the concentration used (5 × 105 M) is a fairly
selective Cox-1 inhibitor (35). Both meclofenamate and
aspirin enhanced NO relaxation specifically in the newborn, whereas
NS-398 was without effect. These results suggested that Cox-1 is
responsible for a reduced vasodilator activity of NO during the first
hours of extrauterine life. This suggestion was also supported by the
further inhibitory effect of arachidonic acid (the substrate of Cox),
specifically in neonates. The fact that the AA-861, an inhibitor of
5-lipooxygenase (which also uses arachidonic acid as its main
substrate), also inhibited NO-induced relaxation specifically in
neonates might be explained also through an increased substrate for
Cox-1. The Cox-1 responsible for the reduced response of NO is not
located in the endothelium because endothelium removal did not affect
the response to NO. Cox-1 produces reactive oxygen species as
byproducts of the synthesis of endoperoxide prostaglandins
(31), which may account for the reduced response to NO in
newborns reported herein. A role for Cox-1-derived superoxide has been
recently suggested to play a major role in the regulation of cerebral
circulation (22). In addition, indomethacin-sensitive Cox-1-dependent NO consumption during prostaglandin synthesis has been
reported to play a physiological role in platelet function (24). However, prostaglandins or thromboxane synthesized
by Cox could also inhibit NO-induced relaxation, even when thromboxane is unlikely to be involved, since the preparations were contracted by a
thromboxane A2 analog at a concentration that produced
70-90% of the maximal response.
We then tested whether the differences in the effects of Cox inhibitors were associated with changes in the expression of Cox proteins. In the late-gestation ovine fetus, pulmonary PGI2 increases acutely with ventilation and enhanced oxygenation (17) resulting from rapid changes in the expression of Cox-1 (22). The lung mRNA and protein expression of the constitutive isoform of Cox (Cox-1) increases six- and twofold, respectively, from fetal to 1-wk-old newborn lambs (6). However, in piglets, we did not find any change in Cox-1 protein expression in the pulmonary arteries. The ovine lung Cox-2 mRNA also increased during the early postnatal period, even when Cox-2 protein was not detected (5). In contrast, Cox-2 was expressed constitutively in piglet cerebral arteries (25) and pulmonary arteries (present results) in both neonates and older animals. A nonsignificant trend for increased expression in the pulmonary arteries from older animals was observed. All these results indicate that the expression of Cox isoforms in the ovine and porcine pulmonary circulations does not change or increases postnatally. Therefore, the Cox-dependent maturation of the responses to NO in newborns reported herein appears to be related to changes in Cox activity, which is not associated with differences in the expression of Cox protein isoforms.
Cox are fundamental enzymes in vascular biology, playing a key role in the pulmonary adaptation to the postnatal circulation (23, 30, 31). Cox-1-dependent inhibition of NO-induced relaxation as described herein is likely to be only part of the role of Cox in the maturation of the pulmonary circulation. In fact, inhibition of Cox in the prenatal period in healthy subjects results in unpaired circulatory adaptation at birth (30) rather than in accelerated maturation. The physiological maturation of endothelial NO is probably more complex that the maturation of the responses to exogenously added NO. However, increased Cox activity may play a role in the development of persistent pulmonary hypertension of the newborn, and it is involved in several experimental models of newborn and adult pulmonary hypertension (30). In addition, Cox-dependent inhibition of NO might participate in the therapeutic failure of inhaled NO.
In conclusion, the present results indicate that, in the pulmonary arteries from newborn piglets, the activity of Cox-1 reduces the vasodilator response to NO, but this mechanism does not operate later in life. Therefore, the present data suggest that the maturational increase in the vasodilator response to NO in the pulmonary arteries during the first days of extrauterine life involves Cox activity.
![]() |
ACKNOWLEDGEMENTS |
---|
We are grateful to Marta Miguel for excellent technical assistance.
![]() |
FOOTNOTES |
---|
This work was supported by SAF 99-069 from the Comisión Interministerial de Ciencia Y Tecnología, BXX 2000-0153 from the Comisión Interministerial de Ciencia Y Tecnología, PR48/01-9893 from the Universidad Complutense de Madrid, and 08.04.36.2001 from the Comunidad Autónoma de Madrid.
Address for reprint requests and other correspondence: F. Pérez-Vizcaíno, Dept. Pharmacology, School of Medicine, Universidad Complutense, 28040 Madrid, Spain (E-mail: fperez{at}ucmail.ucm.es).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajplung.00293.2001
Received 30 July 2001; accepted in final form 14 May 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Abman, SH,
Chatefield BA,
Hall SL,
and
McMurtry IF.
Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth.
Am J Physiol Heart Circ Physiol
259:
H1921-H1927,
1990
2.
Abman, SH,
Chatefield BA,
Rodman DM,
Hall SL,
and
McMurtry IF.
Maturational changes in endothelium-derived relaxing factor activity in ovine pulmonary arteries in vitro.
Am J Physiol Lung Cell Mol Physiol
260:
L280-L285,
1991
3.
Behrends, S,
Kempfert J,
Mietens A,
Koglin M,
Scholz H,
and
Middendorff R.
Developmental changes of nitric oxide-sensitive guanylyl cyclase expression in pulmonary arteries.
Biochem Biophys Res Commun
283:
883-887,
2001[ISI][Medline].
4.
Boels, PJ,
Deutsch J,
Gao B,
and
Haworth SG.
Maturation of the response in resistance and conduit pulmonary arteries.
Cardiovasc Res
44:
416-428,
1999[ISI][Medline].
5.
Brannon, TS,
MacRitchie AN,
Jaramillo MA,
Sherman TS,
Yuhama IS,
Margraf LR,
and
Shaul PW.
Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in the ovine lung.
Am J Physiol Lung Cell Mol Physiol
275:
L66-L71,
1998.
6.
Brannon, TS,
North AJ,
Wells LB,
and
Shaul PW.
Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression.
J Clin Invest
93:
2230-2235,
1994[ISI][Medline].
7.
Cai, H,
and
Harrison DG.
Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress.
Circ Res
87:
840-844,
2000
8.
Cogolludo, AL,
Pérez-Vizcaíno F,
Zaragozá-Arnáez F,
Ibarra M,
López-López JG,
López-Miranda V,
and
Tamargo J.
Mechanisms involved in SNP-induced relaxation and [Ca2+]i reduction in piglet pulmonary and systemic arteries.
Br J Pharmacol
132:
959-967,
2001
9.
Davidson, D.
Pulmonary hemodynamics at birth: effect of acute cyclooxygenase inhibition in lambs.
J Appl Physiol
64:
1676-1682,
1989
10.
Dawes, GS,
Mott JC,
and
Widdecombe JG.
Changes in the lungs of the newborn lamb.
J Physiol (Paris)
121:
141-162,
1953.
11.
Di Wang, H,
Pagano PJ,
Du Y,
Cayatte AJ,
Quinn MT,
Brecher P,
and
Cohen RA.
Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide.
Circ Res
82:
810-818,
1998
12.
Fineman, J,
Soifer S,
and
Heymann M.
Regulation of pulmonary vascular tone in the perinatal period.
Annu Rev Pharmacol Toxicol
57:
115-134,
1995.
13.
Hanson, KA,
Burns F,
Rybalkin SD,
Miller JW,
Beavo J,
and
Clarke WR.
Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message.
Am J Respir Crit Care Med
158:
279-288,
1998
14.
Haworth, S,
and
Hislop A.
Adaptation of the pulmonary circulation to extra-uterine life in the pig and its relevance to the human infant.
Cardiovasc Res
15:
108-119,
1981[ISI][Medline].
15.
Kolber, KA,
Gao Y,
and
Raj JU.
Maturational changes in endothelium-derived nitric oxide-relaxation of ovine pulmonary arteries.
Biol Neonate
77:
123-130,
2000[ISI][Medline].
16.
Laemmli, UK.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1970[ISI][Medline].
17.
Leffler, CW,
Hessler JR,
and
Terragno NA.
Ventilation-induced release of prostaglandin-like material from fetal lungs.
Am J Physiol Heart Circ Physiol
238:
H282-H286,
1980
18.
Liu, S,
Hislop A,
Haworth S,
and
Barnes P.
Developmental changes in endothelium-dependent pulmonary vasodilataion in pigs.
Br J Pharmacol
106:
324-330,
1992[Abstract].
19.
López-López, JG,
Pérez-Vizcaíno F,
Cogolludo AL,
Ibarra M,
Zaragozá-Arnáez F,
and
Tamargo J.
Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries.
Br J Pharmacol
133:
615-624,
2001
20.
Martínez-Orgado, J,
Salaices M,
Rodríguez-Martínez MA,
Sánchez Ferrer CF,
and
Marín J.
Role of nitric oxide on the endothelium-dependent vasodilation in newborn piglet cerebral arteries.
Gen Pharmacol
25:
899-902,
1994[Medline].
21.
Morecroft, I,
and
MacLean MR.
Developmental changes in endothelium-dependent vasodilation and the influence of superoxide anions in perinatal rabbit pulmonary arteries.
Br J Pharmacol
125:
1585-1593,
1998[Abstract].
22.
Niwa, K,
Haensel C,
Ross ME,
and
Iadecola C.
Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation.
Circ Res
88:
600-608,
2001
23.
North, AJ,
Brannon TS,
Wells LB,
Campbell WB,
and
Shaul PW.
Hypoxia stimulates prostacyclin synthesis by increasing cyclooxygenase-1 protein.
Circ Res
75:
33-40,
1994[Abstract].
24.
O'Donnell, VB,
Coles B,
Lewis MJ,
Crews BC,
Marnett LJ,
and
Freeman BA.
Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function.
J Biol Chem
275:
38239-38244,
2000
25.
Parfenova, H,
Massie V,
and
Leffler CW.
Developmental changes in endothelium-derived vasorelaxant factors in cerebral circulation.
Am J Physiol Heart Circ Physiol
278:
H780-H788,
2000
26.
Pérez-Vizcaíno, F,
Cogolludo AL,
Villamor E,
and
Tamargo J.
Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
Br J Pharmacol
123:
847-854,
1998[Abstract].
27.
Pérez-Vizcaíno, F,
Villamor E,
Duarte J,
and
Tamargo J.
Involvement of protein kinase C in reduced relaxant responses to the NO/cGMP pathway in piglet pulmonary arteries contracted by the thromboxane A2 mimetic U46619.
Br J Pharmacol
121:
1323-1333,
1997[Abstract].
28.
Pérez-Vizcaíno, F,
Villamor E,
Moro M,
and
Tamargo J.
Lack of endotoxin-induced hyporesponsiveness to U46619 in isolated neonatal porcine pulmonary but not mesenteric arteries.
J Vasc Res
33:
249-257,
1996[ISI][Medline].
29.
Rairigh, RL,
Parker TA,
Ivy DD,
Kinsella JP,
Fan ID,
and
Abman SH.
Role of inducible nitric oxide synthase in the pulmonary vascular response to birth-related stimuli in the ovine fetus.
Circ Res
88:
721-726,
2001
30.
Shaul, PW.
Regulation of vasodilator synthesis during lung development.
Early Hum Dev
54:
271-294,
1999[ISI][Medline].
31.
Smith, WL,
DeWitt DL,
and
Garavito RM.
Cyclooxygenases: structural, cellular and molecular biology.
Annu Rev Biochem
69:
145-182,
2000[ISI][Medline].
32.
Steinhorn, RH,
Morin FC, III,
Gugino SF,
Giese E,
and
Russell JA.
Developmental differences in endothelium-dependent responses in isolated ovine pulmonary arteries and veins.
Am J Physiol Heart Circ Physiol
264:
H2162-H2167,
1993
33.
Stoen, R,
Brubakk A,
Vik T,
Lossius K,
Jynge P,
and
Karlsson JOG
Postnatal changes in mechanisms mediating acetylcholine-induced relaxation in piglet femoral arteries.
Pediatr Res
41:
702-707,
1997[Abstract].
34.
Villamor, E,
Pérez-Vizcaíno F,
Cogolludo AL,
Conde-Oviedo J,
Zaragozá-Arnáez F,
López-López JG,
and
Tamargo J.
Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets.
Pediatr Res
48:
546-553,
2000
35.
Warner, TD,
Giuliano F,
Voinovic I,
Bukasa A,
Mitchell JA,
and
Vane JR.
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxigenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.
Proc Natl Acad Sci USA
96:
7563-7568,
1999
36.
Zalba, G,
Beaumont FJ,
San Jose G,
Fortuno A,
Fortuno MA,
Etavo JC,
and
Diez J.
Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats.
Hypertension
35:
1055-1061,
2000
37.
Zellers, T,
and
Vanhoutte P.
Endothelium-dependent relaxations in piglet pulmonary arteries augment with maturation.
Pediatr Res
30:
176-180,
1991[Abstract].